Medicus Pharma Ltd. MDCX shares surged to a high of $1.61 before falling during Thursday’s premarket session following the ...
Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...
Investor's Business Daily on MSN
This pharma stock shows strength, eyes entry as earnings surge 59%
Solid pharma stocks offer promising upside opportunities. This particular play is eyeing an entry as earnings surge.
Having successfully navigated the Humira patent cliff, AbbVie is poised for continued growth.
Now, it’s worth noting Stock Advisor’s total average return is 941 % — a market-crushing outperformance compared to 194% for ...
Aurinia Pharmaceutical stock is a "Hold" at current levels. Learn more about Lupkynis' momentum, AUPH's strong FY2025 cash flow, and analyst targets.
Now, it’s worth noting Stock Advisor’s total average return is 951 % — a market-crushing outperformance compared to 194% for ...
The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...
Royalty Pharma plc (NASDAQ:RPRX) is among the 11 Best Low Priced Growth Stocks to Buy Right Now. On February 12, Goldman ...
ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results